Prediction of Disease Relapses by Multi-biomarker Disease Activity Score and Autoantibody Status in RA Patients Tapering DMARD Treatment in Stable Remission

被引：0

作者：

Hagen, Melanie ^{[1
]}

Tascilar, Koray ^{[2
]}

Reiser, Michaela ^{[3
,4
]}

Haschka, Judith ^{[5
]}

Kleyer, Arnd ^{[2
]}

Valor, Larissa ^{[6
]}

Manger, Bernhard ^{[6
]}

Schett, Georg ^{[7
]}

Rech, Juergen ^{[3
,4
]}

机构：

[1] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Hosp Erlangen, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany

[2] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany

[3] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Internal Med 3, Erlangen, Bayern, Germany

[4] Univ Klinikum Erlangen, Erlangen, Bayern, Germany

[5] St Vincent Hosp Vienna, Karl Landsteiner Inst Gastroenterol & Rheumatol, Med Dept 2, Vienna, Austria

[6] Friedrich Alexander Univ Erlangen Nurnberg, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany

[7] Friedrich Alexander Univ Erlangen Nurnberg, Dept Internal Med 3, Erlangen, Germany

来源：

ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2390

引用

页数：2

共 50 条

[1] Prediction of Disease Relapses By Multi-Biomarker Disease Test Activity in Rheumatoid Arthritis Patients Tapering DMARD Treatment
Rech, Juergen
Hueber, Axel J.
Englbrecht, Matthias
Finzel, Stephanie
Haschka, Judith
Manger, Bernhard
Kleyer, Arnd
Reiser, Michaela
Tony, Hans-Peter
Kleinert, Stefan
Feuchtenberger, Martin
Fleck, Martin
Manger, Karin
Ochs, Wolfgang
Schmitt-Haendle, Matthias
Wendler, Joerg
Schuch, Florian
Ronneberger, Monika
Lorenz, Hanns-Martin
Nuesslein, Hubert
Alten, Rieke
Cobra, Jayme Fogagnolo
Henes, Joerg C.
Krueger, Klaus
Schett, Georg A.
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[2] Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment
Rech, Juergen
Hueber, Axel J.
Finzel, Stephanie
Englbrecht, Matthias
Haschka, Judith
Manger, Bernhard
Kleyer, Arnd
Reiser, Michaela
Cobra, Jayme Fogagnolo
Figueiredo, Camille
Tony, Hans-Peter
Kleinert, Stefan
Wendler, Joerg
Schuch, Florian
Ronneberger, Monika
Feuchtenberger, Martin
Fleck, Martin
Manger, Karin
Ochs, Wolfgang
Schmitt-Haendle, Matthias
Lorenz, Hanns-Martin
Nuesslein, Hubert
Alten, Rieke
Henes, Joerg
Krueger, Klaus
Schett, Georg
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (09) : 1637 - 1644
[3] MULTI-BIOMARKER DISEASE ACTIVITY AND AUTOANTIBODY STATUS LEAD TO COST EFFECTIVE TAPERING ALGORITHMS IN RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION
Hagen, M.
Englbrecht, M.
Haschka, J.
Reiser, M.
Kleyer, A.
Hueber, A.
Manger, B.
Figuereido, C.
Cobra, J. Fogagnolo
Tony, H. -P.
Finzel, S.
Kleinert, S.
Wendler, J.
Schuch, F.
Ronneberger, M.
Feuchtenberger, M.
Fleck, M.
Manger, K.
Ochs, W.
Schmitt-Haendle, M.
Lorenz, H. -M.
Nuesslein, H.
Alten, R.
Henes, J.
Krueger, K.
Schett, G.
Rech, J.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 159 - 159
[4] Multi-Biomarker Disease Activity and Autoantibody Status Lead to Cost Effective Tapering Algorithms in Rheumatoid Arthritis Patients in Sustained Remission
Hagen, Melanie
Englbrecht, Matthias
Haschka, Judith
Reiser, Michaela
Kleyer, Arnd
Hueber, Axel J.
Manger, Bernhard
Figueiredo, Camille
Cobra, Jayme Fogagnolo
Tony, Hans-Peter
Finzel, Stefanie
Kleinert, Stefan
Wendler, Joerg
Schuch, Florian
Ronneberger, Monika
Feuchtenberger, Martin
Fleck, Martin
Manger, Karin
Schmitt-Haendle, Matthias
Lorenz, H. -M.
Nusslein, H. G.
Alten, Rieke
Henes, Joerg C.
Kruger, Klaus
Schett, Georg
Rech, Juergen
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[5] THE MULTI-BIOMARKER DISEASE ACTIVITY SCORE FOR ASSESSING RESPONSE TO TREATMENT WITH ADALIMUMAB
Pappas, D.
Sasso, E. H.
Bolce, R. J.
Liu, X.
Etzel, C. J.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1121 - 1121
[6] A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis
M. H. Y. Ma
N. Defranoux
W. Li
E. H. Sasso
F. Ibrahim
D. L. Scott
A. P. Cope
Arthritis Research & Therapy, 22
[7] A MULTI-BIOMARKER DISEASE ACTIVITY SCORE (THE VECTRA DA ALGORITHM SCORE) REFLECTS CLINICAL REMISSION FOR RHEUMATOID ARTHRITIS (RA) IN THE BEST STUDY
Hirata, S.
Dirven, L.
Gavel, G.
Centola, M.
Lems, W. F.
Tanaka, Y.
Huizinga, T. W.
Allaart, C. F.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 355 - 355
[8] A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis
Ma, M. H. Y.
Defranoux, N.
Li, W.
Sasso, E. H.
Ibrahim, F.
Scott, D. L.
Cope, A. P.
ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
[9] ELEVATED MULTI-BIOMARKER DISEASE ACTIVITY (MBDA) PREDICTS RELAPSES IN RA PATIENTS IN SUSTAINED REMISSION TAPERING TUMOUR NECROSIS FACTOR INHIBITOR THERAPY-RESULTS FROM THE RANDOMIZED CONTROLLED RETRO STUDY
Rech, J.
Hagen, M.
Englbrecht, M.
Haschka, J.
Reiser, M.
Kleyer, A.
Hueber, A.
Manger, B.
Figuereido, C.
Cobra, J. Fogagnolo
Tony, H-P.
Finzel, S.
Kleinert, S.
Wendler, J.
Schuch, F.
Ronneberger, M.
Feuchtenberger, M.
Fleck, M.
Manger, K.
Ochs, W.
Schmitt-Haendle, M.
Lorenz, H-M.
Nuesslein, H.
Alten, R.
Henes, J.
Krueger, K.
Schett, G.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 516 - 517
[10] A COMBINATION OF PROTEINS AS MEASURED WITHIN THE MULTI-BIOMARKER DISEASE ACTIVITY SCORE AT PRESENTATION OF RA IDENTIFIES A GROUP OF ACPA-NEGATIVE RA PATIENTS WITH HIGH LIKELIHOOD OF DEVELOPING DMARD-FREE SUSTAINED REMISSION
Boeters, D. M.
Burgers, L. E.
Huizinga, T. W.
van der Helm-van Mil, A. H.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 135 - 135

← 1 2 3 4 5 →